This population-based study uses data from the Zurich Cohort Study to assess the persistence of mental health disorders in adults using 7 interviews conducted across 29 years in Switzerland.
This longitudinal cohort study uses data from the National Medicaid Analytic Extract and the National Center for Health Statistics to assess the postdischarge risk for suicide among psychiatric inpatients.
This genome-wide association study assesses analyses from 3 studies of substance use disorder genetics to identify DSM-IV criteria for cannabis dependence in a large African American and European American cohort.
This cohort study uses national survey data to examine associations between cannabis use and risk of mental health and substance use disorders in the general US adult population.
This cohort study, using a national longitudinal registry, estimates mortality risk of persons with obsessive-compulsive disorder compared with those without this disorder.
This review article summarizes what is known about the effects of cannabis use on human behavior, including cognition, motivation, and psychosis.
This survey study presents nationally representative findings on the prevalence, correlates, psychiatric comorbidity, disability, and treatment of DSM-5 drug use disorder diagnoses overall and by severity level.
This study reports that the prevalence of marijuana use more than doubled between 2001-2002 and 2012-2013 and marijuana use disorders have increased as well.
This survey of Vietnam war veterans with posttraumatic stress disorder symptoms who underwent a similar assessment 25 years ago suggests that symptoms remain during the 4 decades after the war and that more than twice as many experience deterioration of symptoms compared with improvement.
This cross-sectional analysis of a nationally representative sample of US adolescents finds that further attention to developing and implementing evidence-based strategies to decrease firearm access in this age group is warranted to prevent suicide.
This prospective longitudinal study shows that, although prevalence rates of psychiatric comorbidity decreased in youth after detention, rates remained substantial and were higher than rates in the most comparable studies of the general population.
This prospective cohort study reports that achieving remission from a substance use disorder does not typically lead to drug substitution, but rather is associated with a lower risk of new substance use disorder onsets.
Van Dam et al identify structural neural characteristics independently associated with childhood maltreatment, comparing a sample with substance use disorders with a demographically comparable control sample, and they examine the relationship between childhood maltreatment–related structural brain changes and subsequent relapse.
Bowen et al compared the long-term efficacy of mindfulness-based relapse prevention with the efficacy of cognitive-behavioral relapse prevention and treatment as usual in participants who had successfully completed initial treatment for substance use disorders.
Meara and colleagues evaluated the association between health insurance coverage expansions and use of hospital-based care among young adults with behavioral health diagnoses.
Cummings et al examine the availability of outpatient substance use disorder treatment facilities that accept Medicaid across US counties and whether counties with a higher percentage of racial/ethnic minorities are more likely to have gaps in this infrastructure.
Wen et al examine the effect of state-level substance use disorder (SUD) parity laws on state-aggregate SUD treatment rates and the effect of recent federal SUD parity legislation.
Humphreys and coauthors meta-analyze the longitudinal association between treatment with stimulant medication during childhood and later substance use disorders.